AAAAAA

   
Results: 1-24 |
Results: 24
Tandem high-dose chemotherapy in high-risk primary breast cancer: A multivariate analysis and a matched-pair comparison with standard-dose chemotherapy
Authors: Schneeweiss, A Goerner, R Hensel, M Lauschner, I Sinn, P Kaul, S Egerer, G Beldermann, F Geberth, M Solomayer, E Grischke, EM Haas, R Ho, AD Bastert, G
Citation: A. Schneeweiss et al., Tandem high-dose chemotherapy in high-risk primary breast cancer: A multivariate analysis and a matched-pair comparison with standard-dose chemotherapy, BIOL BLOOD, 7(6), 2001, pp. 332-342
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma
Authors: Neben, K Moehler, T Egerer, G Kraemer, A Hillengass, J Benner, A Ho, AD Goldschmidt, H
Citation: K. Neben et al., High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma, CLIN CANC R, 7(9), 2001, pp. 2675-2681
Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer
Authors: Schneeweiss, A Hensel, M Goerner, R Khbeis, T Hohaus, S Egerer, G Solomayer, E Haas, R Grischke, EM Bastert, G Ho, AD
Citation: A. Schneeweiss et al., Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer, STEM CELLS, 19(2), 2001, pp. 151-160
Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia
Authors: Egerer, G Sauerland, K Ho, AD
Citation: G. Egerer et al., Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia, LEUK LYMPH, 42(3), 2001, pp. 551-553
Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone
Authors: Egerer, G Hegenbart, U Salwender, H Haas, R Hahn, U Schmier, JW Ho, AD Goldschmidt, H
Citation: G. Egerer et al., Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone, SUPP CARE C, 9(5), 2001, pp. 380-385
Altered self-reactive antibody repertoires are a general feature of patients with myelodysplastic syndrome
Authors: Stahl, D Egerer, G Goldschmidt, H Sibrowski, W Kazatchkine, MD Kaveri, SV
Citation: D. Stahl et al., Altered self-reactive antibody repertoires are a general feature of patients with myelodysplastic syndrome, J AUTOIMMUN, 16(1), 2001, pp. 77-86
Successful treatment of bronchiolitis obliterans organizing pneumonia withlow-dose methotrexate in a patient with Hodgkin's disease
Authors: Egerer, G Witzens, M Spaeth, A Breitbart, A Moller, P Goldschmidt, H Ho, AD
Citation: G. Egerer et al., Successful treatment of bronchiolitis obliterans organizing pneumonia withlow-dose methotrexate in a patient with Hodgkin's disease, ONCOL-BASEL, 61(1), 2001, pp. 23-27
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging
Authors: Moehler, TM Hawighorst, H Neben, K Egerer, G Hillengass, J Max, R Benner, A Ho, AD van Kaick, G Goldschmidt, H
Citation: Tm. Moehler et al., Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging, INT J CANC, 93(6), 2001, pp. 862-868
Ceftriaxone for the treatment of febrile episodes in nonneutropenic patients with hematooncological disease or HIV infection: Comparison of outpatient and inpatient care
Authors: Egerer, G Goldschmidt, H Muller, I Karthaus, M Gunther, H Ho, AD
Citation: G. Egerer et al., Ceftriaxone for the treatment of febrile episodes in nonneutropenic patients with hematooncological disease or HIV infection: Comparison of outpatient and inpatient care, CHEMOTHERA, 47(3), 2001, pp. 219-225
Continuous complete remission in adult patients with acute lymphocytic leukaemia at a median observation of 12 years after autologous bone marrow transplantation
Authors: Abdallah, A Egerer, G Goldschmidt, H Wannenmacher, M Korbling, M Ho, AD
Citation: A. Abdallah et al., Continuous complete remission in adult patients with acute lymphocytic leukaemia at a median observation of 12 years after autologous bone marrow transplantation, BR J HAEM, 112(4), 2001, pp. 1012-1015
Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy
Authors: Moehler, TM Neben, K Benner, A Egerer, G Krasniqi, F Ho, AD Goldschmidt, H
Citation: Tm. Moehler et al., Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy, BLOOD, 98(13), 2001, pp. 3846-3848
High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors
Authors: Neben, K Hohaus, S Goldschmidt, H Egerer, G Voso, MT Ho, AD Haas, R
Citation: K. Neben et al., High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors, ANN HEMATOL, 79(10), 2000, pp. 547-555
Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation
Authors: Egerer, G Goldschmidt, H Salwender, H Hegenbart, U Ehrhard, I Haas, R Ho, AD
Citation: G. Egerer et al., Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation, INT J ANT A, 15(2), 2000, pp. 119-123
Autologous and allogeneic stem cell transplantation in multiple myeloma
Authors: Goldschmidt, H Egerer, G Ho, AD
Citation: H. Goldschmidt et al., Autologous and allogeneic stem cell transplantation in multiple myeloma, BONE MAR TR, 25, 2000, pp. S25-S26
Antimicrobial therapy in neutropenic patients
Authors: Egerer, G Karthaus, M Goldschmidt, H Ho, AD
Citation: G. Egerer et al., Antimicrobial therapy in neutropenic patients, ANTIB CHEMY, 50, 2000, pp. 20-25
Interventional once-daily administration of ceftriaxone in leukemia and lymphoma patients with febrile neutropenia
Authors: Karthaus, M Sudhoff, T Egerer, G Fenchel, K Kampfe, D Ritter, J Franke, A Heil, G Peters, G Jurgens, H
Citation: M. Karthaus et al., Interventional once-daily administration of ceftriaxone in leukemia and lymphoma patients with febrile neutropenia, ANTIB CHEMY, 50, 2000, pp. 26-36
Outpatient treatment of cancer patients with fever and neutropenia
Authors: Karthaus, M Egerer, G Jurgens, H
Citation: M. Karthaus et al., Outpatient treatment of cancer patients with fever and neutropenia, ANTIB CHEMY, 50, 2000, pp. 47-58
Recombinant human erythropoietin in the treatment of cancer
Authors: Stilgenbauer, F Egerer, G Karthaus, M Goldschmidt, H Ho, AD
Citation: F. Stilgenbauer et al., Recombinant human erythropoietin in the treatment of cancer, ANTIB CHEMY, 50, 2000, pp. 106-114
Central venous catheter-related complications
Authors: Salwender, HJ Egerer, G Bach, A Hahn, U Goldschmidt, H Ho, AD
Citation: Hj. Salwender et al., Central venous catheter-related complications, ANTIB CHEMY, 50, 2000, pp. 133-143
Treatment of chemotherapy-induced emesis
Authors: Egerer, G Hegenbart, U Salwender, HJ Goldschmidt, H Ho, AD
Citation: G. Egerer et al., Treatment of chemotherapy-induced emesis, ANTIB CHEMY, 50, 2000, pp. 171-183
Functional magnetic resonance imaging for detection and monitoring of bonelesions in multiple myeloma
Authors: Moehler, TM Hawighorst, H Neben, K Egerer, G Benner, A Hillengass, J Max, R Ho, AD Goldschmidt, H van Kaick, G
Citation: Tm. Moehler et al., Functional magnetic resonance imaging for detection and monitoring of bonelesions in multiple myeloma, RADIOLOGE, 40(8), 2000, pp. 723-730
Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support
Authors: Egerer, G Goldschmidt, H Streich, N Ehrhard, I Sonntag, HG Haas, R
Citation: G. Egerer et al., Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support, SUPP CARE C, 7(5), 1999, pp. 336-342
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
Authors: Hohaus, S Funk, L Martin, S Schlenk, RF Abdallah, A Hahn, U Egerer, G Goldschmidt, H Schneeweiss, A Fersis, N Kaul, S Wallwiener, D Bastert, G Haas, R
Citation: S. Hohaus et al., Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer, BR J CANC, 79(9-10), 1999, pp. 1500-1507
A case of mu heavy-chain disease associated with hyperglobulinemia, anemia, and a positive Coombs test
Authors: Witzens, M Egerer, G Stahl, D Werle, E Goldschmidt, H Haas, R
Citation: M. Witzens et al., A case of mu heavy-chain disease associated with hyperglobulinemia, anemia, and a positive Coombs test, ANN HEMATOL, 77(5), 1998, pp. 231-234
Risultati: 1-24 |